Doctors test which bone drug works better for women at high fracture risk
NCT ID NCT05010590
Summary
This study aims to compare how well two different FDA-approved osteoporosis medications work to strengthen bones in postmenopausal women at high risk of fractures. Researchers will follow 50 participants for 12 months, measuring changes in hip bone density. The goal is to help doctors choose the most effective treatment to control osteoporosis and prevent broken bones.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTMENOPAUSAL OSTEOPOROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.